Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in LYEL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,222,571
+$1,574,299 QoQ
Shares Held
310,198
+105.4% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Derivatives in LYEL

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$258,552
PutShares
8,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. LYEL ranks #46 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LYEL

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,222,571 310,198
2025-12-31 $258,552 8,400
2025-12-31 $4,648,272 151,016
2025-09-30 $262,422 16,159
2025-06-30 $198,016 22,400